Bortezomib, Doxorubicin and Dexamethasone in Advanced Multiple Myeloma Advanced multiple myeloma treatment -- discover the results of a first time combination of bortezomib, doxorubicin and low-dose ...

The regulatory landscape for MM has undergone substantial transformation, with multiple novel therapeutic agents receiving US Food and Drug Administration approval within the preceding few years based ...

Early stage multiple myeloma is often asymptomatic, and early symptoms can be subtle and easy to miss. Delayed diagnosis and treatment may affect survival. Possible early symptoms include bone pain, ...

Multiple myeloma is considered to be relapsed if symptoms of the disease appear after a time of improvement. It’s considered to be refractory when it gets worse even though it’s being treated. To ...

This ASCO Living Guideline is reviewed on an eight-week cycle. Please see the online dynamic version for the latest updates. ASCO Guidelines provide recommendations ...

Multiple myeloma is a type of blood cancer that starts in your bone marrow. This is the soft, spongy tissue inside your bones that makes most of your blood cells. It includes plasma cells, which help ...

Lindsay Curtis is a health & medical writer in South Florida. She worked as a communications professional for health nonprofits and the University of Toronto’s Faculty of Medicine and Faculty of ...

Gagandeep Brar, MD, is a board-certified hematologist and medical oncologist. Her research interest is in gastrointestinal malignancies with a focus on immune and targeted therapies. Smoldering ...

The different types of multiple myeloma (MM) are typical myeloma, light chain multiple myeloma (LCMM), nonsecretory myeloma (NSM), and IgM myeloma. Multiple myeloma (MM) is a type of blood and bone ...

Multiple myeloma starts with genetic changes in plasma cells, which are not inherited but occur spontaneously. The condition progresses from monoclonal gammopathy of undetermined significance (MGUS) ...